Kovack Advisors Inc. Has $449,000 Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Kovack Advisors Inc. cut its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 13.4% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 4,549 shares of the exchange traded fund’s stock after selling 705 shares during the period. Kovack Advisors Inc.’s holdings in SPDR S&P Biotech ETF were worth $449,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Healthcare of Ontario Pension Plan Trust Fund raised its stake in SPDR S&P Biotech ETF by 30.3% during the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,136,000 shares of the exchange traded fund’s stock worth $297,575,000 after buying an additional 730,000 shares during the period. Northwestern Mutual Wealth Management Co. raised its position in shares of SPDR S&P Biotech ETF by 1.6% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,145,049 shares of the exchange traded fund’s stock worth $106,158,000 after purchasing an additional 18,202 shares during the period. Jane Street Group LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 68.7% during the 1st quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock valued at $91,197,000 after purchasing an additional 391,333 shares in the last quarter. Bessemer Group Inc. grew its position in shares of SPDR S&P Biotech ETF by 1.7% in the 1st quarter. Bessemer Group Inc. now owns 922,871 shares of the exchange traded fund’s stock valued at $87,572,000 after purchasing an additional 15,794 shares during the period. Finally, Employees Retirement System of Texas grew its position in shares of SPDR S&P Biotech ETF by 40.8% in the 2nd quarter. Employees Retirement System of Texas now owns 603,857 shares of the exchange traded fund’s stock valued at $55,984,000 after purchasing an additional 174,857 shares during the period.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI stock opened at $96.96 on Friday. The company has a market capitalization of $7.39 billion, a P/E ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 52 week low of $69.32 and a 52 week high of $105.47. The company’s 50 day moving average price is $99.04 and its two-hundred day moving average price is $95.99.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.